secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001683168-23-007912
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical appoints James B. Frakes as Interim CEO; Charles J. Fisher Jr. departs
--------------------------------------------------------------------------------

- Charles J. Fisher Jr., M.D. departed as CEO effective Nov 7, 2023; Guy F. Cipriani resigned as director.
- James B. Frakes appointed as Interim CEO and Board member, retains CFO role.
- Guy F. Cipriani appointed as Senior VP and COO; resigned from Board.
- Frakes' base salary $360,000 (set Jan 2023); eligible for discretionary bonus.
- Company plans amended employment agreements for Frakes and Cipriani.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/0001683168-23-007912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316823007912/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-007912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer